Health
Study Finds Cycling JAK Inhibitors Effective Option for Patients with Difficult-to-Treat RA – Newswise
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people…
Newswise — ATLANTA — New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with difficult-to-treat rheumatoid arthritis who do not have success with one Janus kinase inhibitor (JAK…
Continue Reading